For more information:

TBD PHARMATECH OÜ

Finances and assets
The average monthly turnover is 568,174 EUR, the profit margin is 0%, the forecast turnover in 2024 will decrease by 51.4%. As of the property...

Estimated turnover 2024

6 818 093 â‚¬

Increased by 51.4 % compared to last year

Average monthly turnover

568 174 â‚¬

Available credit: 100 000 â‚¬
Settlement dates: 30

Total profit 2024

5 549 285 â‚¬

Retained profits:
5 233 404 â‚¬ (94 %)
Net profit:
315 881 â‚¬ (6 %)

Estimated
balance 2024

6 571 229 â‚¬

Estimated profit
margin 2024

0 %
100 %

5%

€1 asset to cover short-term liabilities

4.89 €

The main activity of TBD Pharmatech is fine chemistry and synthesis services and small-scale production of active pharmaceutical ingredients. The company's main customers are chemical, pharmaceutical and biotechnology

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is as of today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.